About the Authors

Rana Nagarkatti

Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, Bethesda, Maryland, United States of America

Fernanda Fortes de Araujo

Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, Bethesda, Maryland, United States of America

Charu Gupta

Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, Bethesda, Maryland, United States of America

Alain Debrabant

alain.debrabant@fda.hhs.gov

Affiliation Laboratory of Emerging Pathogens, Division of Emerging and Transfusion Transmitted Diseases, Center for Biologics Evaluation and Research, U. S. Food and Drug Administration, Bethesda, Maryland, United States of America

Competing Interests

The authors have declared that no competing interests exist.

Author Contributions

Conceived and designed the experiments: RN AD. Performed the experiments: RN FFA CG. Analyzed the data: RN FFA AD. Contributed reagents/materials/analysis tools: RN FFA AD. Wrote the paper: RN FFA AD.